Detalles de la búsqueda
1.
The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).
Mol Psychiatry
; 21(11): 1499-1503, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27480491
2.
Chronic treatment with enhancer drugs modifies the gene expression of selected parameters related to brain plasticity in rats under stress conditions.
Neurochem Int
; 159: 105404, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853552
3.
A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain.
Life Sci
; 182: 57-64, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28623006
4.
Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP).
Life Sci
; 167: 32-38, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27777099
5.
(-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Br J Pharmacol
; 128(8): 1723-32, 1999 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-10588928
6.
Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication.
Life Sci
; 56(8): 611-20, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-7869839
7.
Analysis of the effect of (-)-BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Life Sci
; 72(25): 2915-21, 2003 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-12697274
8.
High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers.
Life Sci
; 58(11): 945-52, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8786700
9.
A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study.
Life Sci
; 72(23): 2641-8, 2003 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-12672509
10.
An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats.
Life Sci
; 72(25): 2923-30, 2003 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-12697275
11.
Sexual hormones terminate in the rat: the significantly enhanced catecholaminergic/serotoninergic tone in the brain characteristic to the post-weaning period.
Life Sci
; 67(7): 765-73, 2000 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-10968406
12.
Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference.
Life Sci
; 54(15): 1047-57, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-8152326
13.
(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons.
Life Sci
; 58(10): 817-27, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8602114
14.
Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain.
Life Sci
; 58(23): 2101-14, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8649195
15.
Analysis of the analgesic and anti-inflammatory effects of rimazolium, a pyrido-pyrimidine derivative, compared with that of prostaglandin synthesis inhibitors and morphine.
Drugs Exp Clin Res
; 11(8): 493-500, 1985.
Artículo
en Inglés
| MEDLINE | ID: mdl-3879753
16.
Treatment possibilities of Alzheimer's disease.
Neuropsychopharmacol Hung
; 6(4): 200-9, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15825676
17.
A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
Pol J Pharmacol Pharm
; 40(6): 561-72, 1988.
Artículo
en Inglés
| MEDLINE | ID: mdl-2908362
18.
Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
Arch Int Pharmacodyn Ther
; 328(1): 1-15, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7893186
19.
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Bioorg Med Chem
; 9(5): 1197-212, 2001 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11377178
20.
The selectivity of highly purified bovine liver angiohypotensin towards resistance vessels.
Acta Physiol Hung
; 75 Suppl: 179-80, 1990.
Artículo
en Inglés
| MEDLINE | ID: mdl-2371856